Grey Wolf Animal Health Corp.
WOLF.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.78M | 5.06M | 5.26M | 4.48M | 4.53M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.78M | 5.06M | 5.26M | 4.48M | 4.53M |
| Cost of Revenue | 2.38M | 2.49M | 2.50M | 2.18M | 2.27M |
| Gross Profit | 2.40M | 2.57M | 2.76M | 2.31M | 2.26M |
| SG&A Expenses | 2.26M | 1.77M | 1.83M | 1.88M | 2.14M |
| Depreciation & Amortization | 244.50K | 189.70K | 188.90K | 190.70K | 210.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.88M | 4.44M | 4.51M | 4.25M | 4.62M |
| Operating Income | -107.00K | 615.80K | 746.90K | 234.70K | -91.40K |
| Income Before Tax | -299.30K | 533.50K | 660.10K | 133.40K | -169.60K |
| Income Tax Expenses | 58.70K | 165.30K | 238.00K | 39.90K | 39.10K |
| Earnings from Continuing Operations | -358.00K | 368.20K | 422.10K | 93.50K | -208.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -358.00K | 368.20K | 422.10K | 93.50K | -208.70K |
| EBIT | -107.00K | 615.80K | 746.90K | 234.70K | -91.40K |
| EBITDA | 226.00K | 854.10K | 981.40K | 471.30K | 141.80K |
| EPS Basic | -0.01 | 0.01 | 0.01 | 0.00 | -0.01 |
| Normalized Basic EPS | -0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| EPS Diluted | -0.02 | 0.01 | 0.01 | 0.00 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 25.06M | 31.03M | 31.03M | 31.03M | 28.39M |
| Average Diluted Shares Outstanding | 25.06M | 31.03M | 31.03M | 31.03M | 28.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |